The neurovascular unit and combination treatment strategies for stroke

Trends in Pharmacological Sciences

Volumn 33, Issue 8, 2012, Pages 415-422

  Zhang, Li ^a   Zhang, Zheng Gang ^a   Chopp, Michael ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ATORVASTATIN; BORTEZOMIB; DISUFENTON SODIUM; ERYTHROPOIETIN; FIBRINOGEN; FIBRINOLYTIC AGENT; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; LACTACYSTIN BETA LACTONE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; NORPHENAZONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASOME INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 1; ROSUVASTATIN; SCAVENGER; SIMVASTATIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTROCYTE; BACTERIAL INFECTION; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN ISCHEMIA; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; EMBOLIC STROKE; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEMODYNAMICS; HUMAN; INFLAMMATION; INNATE IMMUNITY; ISCHEMIC PENUMBRA; LOW DRUG DOSE; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIPLE MYELOMA; NERVE CELL; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION; REVIEW; STROKE; THROMBECTOMY; TISSUE INJURY; TRANSIENT ISCHEMIC ATTACK; UPREGULATION;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CEREBRAL HEMORRHAGE; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FIBRINOLYTIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MINOCYCLINE; PYRAZINES; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84864281309     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.04.006     Document Type: Review

References (150)

1. W. Hacke Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N. Engl. J. Med. 359 2008 1317 1329
2. O. Adeoye Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years Stroke 42 2011 1952 1955
3. D. Kleindorfer National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate Stroke 39 2008 924 928 (Pubitemid 351619542)
4. G.C. Fonarow Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes Circulation 123 2011 750 758
5. M. Lee Blood-brain barrier permeability derangements in posterior circulation ischemic stroke: frequency and relation to hemorrhagic transformation J. Neurol. Sci. 313 2012 142 146
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N. Engl. J. Med. 333 1995 1581 1587
7. M.A. Moskowitz The science of stroke: mechanisms in search of treatments Neuron 67 2010 181 198
8. J.C. Chavez Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch Stroke 40 2009 e558 e563
9. E.H. Lo Mechanisms, challenges and opportunities in stroke Nat. Rev. Neurosci. 4 2003 399 415 (Pubitemid 37280178)
10. P.A. Lapchak Effects of the spin trap agent disodium-[tert-butylimino) methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit. Large clot embolic stroke model: combination studies with tissue plasminogen activator Stroke 33 2002 1665 1670 (Pubitemid 34619976)
11. M.D. Ginsberg Neuroprotection for ischemic stroke: past, present and future Neuropharmacology 55 2008 363 389
12. S. Guo, and E.H. Lo Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease Stroke 40 2009 S4 S7
13. M.D. Ginsberg Current status of neuroprotection for cerebral ischemia: synoptic overview Stroke 40 2009 S111 S114
14. V.E. O'Collins 1,026 experimental treatments in acute stroke Ann. Neurol. 59 2006 467 477 (Pubitemid 43358067)
15. G.Z. Feuerstein Missing steps in the STAIR case: a translational medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke J. Cereb. Blood Flow Metab. 28 2008 217 219
16. E.H. Lo A new penumbra: transitioning from injury into repair after stroke Nat. Med. 14 2008 497 500 (Pubitemid 351655209)
17. S. Zacchigna Neurovascular signalling defects in neurodegeneration Nat. Rev. Neurosci. 9 2008 169 181 (Pubitemid 351272665)
18. G.J. del Zoppo The neurovascular unit in the setting of stroke J. Intern. Med. 267 2010 156 171
19. C. Iadecola, and M. Nedergaard Glial regulation of the cerebral microvasculature Nat. Neurosci. 10 2007 1369 1376 (Pubitemid 350014688)
20. H. Zhu Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke J. Cereb. Blood Flow Metab. 30 2010 1137 1146
21. L. Zhang Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia Stroke 41 2010 1001 1007
22. L. Zhang Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat Circulation 112 2005 3486 3494 (Pubitemid 43739565)
23. N. Fujiwara Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke BMC Neurosci. 10 2009 79
24. B.V. Zlokovic, and J.H. Griffin Cytoprotective protein C pathways and implications for stroke and neurological disorders Trends Neurosci. 34 2011 198 209
25. P. Ramos-Cabrer Targeting the ischemic penumbra Stroke 42 2011 S7 S11
26. M. Fisher The ischemic penumbra: a new opportunity for neuroprotection Cerebrovasc. Dis. 21 Suppl. 2 2006 64 70
27. F.R. Sharp Multiple molecular penumbras after focal cerebral ischemia J. Cereb. Blood Flow Metab. 20 2000 1011 1032 (Pubitemid 30445613)
28. A. Armulik Pericytes regulate the blood-brain barrier Nature 468 2010 557 561
29. M. Mae Getting to know the cast - cellular interactions and signaling at the neurovascular unit Curr. Pharm. Des. 17 2011 2750 2754
30. P. Ballabh The blood-brain barrier: an overview: structure, regulation, and clinical implications Neurobiol. Dis. 16 2004 1 13 (Pubitemid 38569790)
31. J. Lok Cell-cell signaling in the neurovascular unit Neurochem. Res. 32 2007 2032 2045 (Pubitemid 350059847)
32. G.J. del Zoppo, and J.M. Hallenbeck Advances in the vascular pathophysiology of ischemic stroke Thromb. Res. 98 2000 73 81
33. A. Rosell Mechanisms and markers for hemorrhagic transformation after stroke Acta Neurochir. Suppl. 105 2008 173 178
34. X.S. Liu Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection J. Cereb. Blood Flow Metab. 26 2006 787 796
35. Z.G. Zhang Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats J. Neurosci. 19 1999 10898 10907 (Pubitemid 30235734)
36. A. Rosell, and E.H. Lo Multiphasic roles for matrix metalloproteinases after stroke Curr. Opin. Pharmacol. 8 2008 82 89
37. M. Yemisci Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery Nat. Med. 15 2009 1031 1037
38. G.J. del Zoppo, and R. Milner Integrin-matrix interactions in the cerebral microvasculature Arterioscler. Thromb. Vasc. Biol. 26 2006 1966 1975 (Pubitemid 44253776)
39. M. Tagaya Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury J. Cereb. Blood Flow Metab. 21 2001 835 846 (Pubitemid 32613538)
40. S. Wagner Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/reperfusion Stroke 28 1997 858 865 (Pubitemid 27161475)
41. D. Constantin Neisseria meningitidis-induced death of cerebrovascular endothelium: mechanisms triggering transcriptional activation of inducible nitric oxide synthase J. Neurochem. 89 2004 1166 1174 (Pubitemid 38715834)
42. S. Chakravarty, and M. Herkenham Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines J. Neurosci. 25 2005 1788 1796 (Pubitemid 40279284)
43. A.K. Singh, and Y. Jiang How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 201 2004 197 207 (Pubitemid 39023946)
44. M.L. Zhou Expression of Toll-like receptor 4 in the brain in a rabbit experimental subarachnoid haemorrhage model Inflamm. Res. 56 2007 93 97
45. G. Ziegler TLR2 has a detrimental role in mouse transient focal cerebral ischemia Biochem. Biophys. Res. Commun. 359 2007 574 579 (Pubitemid 46898990)
46. S.C. Tang Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits Proc. Natl. Acad. Sci. U.S.A. 104 2007 13798 13803
47. T. Abe Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia Stroke 41 2010 898 904
48. B.J. Marsh Toll-like receptor signaling in endogenous neuroprotection and stroke Neuroscience 158 2009 1007 1020
49. R. Medzhitov A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 388 1997 394 397 (Pubitemid 27334820)
50. S. Akira Toll-like receptors: critical proteins linking innate and acquired immunity Nat. Immunol. 2 2001 675 680 (Pubitemid 32747155)
51. P. Nagyoszi Expression and regulation of toll-like receptors in cerebral endothelial cells Neurochem. Int. 57 2010 556 564
52. J.R. Caso Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke Circulation 115 2007 1599 1608 (Pubitemid 46648645)
53. P. Nagyoszi Expression and regulation of toll-like receptors in cerebral endothelial cells Neurochem. Int. 57 2010 556 564
54. J. Qiu High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia Stroke 41 2010 2077 2082
55. L. Jia Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke Stroke 41 2010 2071 2076
56. X. Wang Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy CNS Neurol. Disord. Drug Targets 7 2008 235 242
57. A. Rosell MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke Stroke 39 2008 1121 1126 (Pubitemid 351440679)
58. M. Rodriguez-Yanez Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke Stroke 42 2011 2813 2818
59. D. Brea Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values J. Cereb. Blood Flow Metab. 31 2011 1424 1431
60. S.M. Davis Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial Lancet Neurol. 7 2008 299 309
61. G.J. del Zoppo Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Ann. Neurol. 32 1992 78 86
62. R. von Kummer, and W. Hacke Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke Stroke 23 1992 646 652
63. C. Berger Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 32 2001 1330 1335 (Pubitemid 32530418)
64. V. Larrue Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II) Stroke 32 2001 438 441 (Pubitemid 32155231)
65. A.M. Pancioli Combination pharmacotherapy for achievement and maintenance of vascular patency Stroke 40 2009 S99 S102
66. C.A. Molina Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes Stroke 35 2004 486 490 (Pubitemid 38174434)
67. M. Ribo Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients Stroke 36 2005 1705 1709 (Pubitemid 41098766)
68. S.H. Kim Plasma fibrinolysis inhibitor levels in acute stroke patients with thrombolysis failure J. Clin. Neurol. 1 2005 142 147
69. D. Vivien Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence J. Cereb. Blood Flow Metab. 31 2011 2119 2134
70. R. Polavarapu Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit Blood 109 2007 3270 3278 (Pubitemid 46572512)
71. M. Yepes Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic Trends Neurosci. 32 2009 48 55
72. P.A. Lapchak Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke Stroke 31 2000 3034 3040
73. T. Sumii, and E.H. Lo Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats Stroke 33 2002 831 836 (Pubitemid 34204013)
74. T. Pfefferkorn, and G.A. Rosenberg Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion Stroke 34 2003 2025 2030 (Pubitemid 36944801)
75. J. Montaner Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke Circulation 107 2003 598 603 (Pubitemid 36176811)
76. S. Warach, and L.L. Latour Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption Stroke 35 2004 2659 2661 (Pubitemid 39458362)
77. O. Nicole The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling Nat. Med. 7 2001 59 64
78. K. Benchenane Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis Circulation 111 2005 2241 2249 (Pubitemid 40632441)
79. Y.F. Wang Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice Nat. Med. 4 1998 228 231 (Pubitemid 28138083)
80. S.E. Tsirka Neuronal cell death and tPA Nature 384 1996 123 124
81. E.H. Lo tPA and proteolysis in the neurovascular unit Stroke 35 2004 354 356 (Pubitemid 38174404)
82. W.P. Fay High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi Arterioscler. Thromb. Vasc. Biol. 16 1996 1277 1284 (Pubitemid 26339716)
83. L.A. Robbie Proteins of the fibrinolytic system in human thrombi Thromb. Haemost. 75 1996 127 133 (Pubitemid 26051206)
84. M. Kelly-Hayes The influence of gender and age on disability following ischemic stroke: the Framingham study J. Stroke Cerebrovasc. Dis. 12 2003 119 126 (Pubitemid 36870484)
85. P.M. Rothwell Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) Lancet 366 2005 1773 1783 (Pubitemid 41642641)
86. L. Park Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain J. Cereb. Blood Flow Metab. 27 2007 1908 1918 (Pubitemid 350129160)
87. W.G. Mayhan Age-related alterations in reactivity of cerebral arterioles: role of oxidative stress Microcirculation 15 2008 225 236
88. K.A. Hossmann Viability thresholds and the penumbra of focal ischemia Ann. Neurol. 36 1994 557 565
89. J.E. Simpson Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain Neurosci. Lett. 486 2010 246 251
90. J. Kaur Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly J. Cereb. Blood Flow Metab. 31 2011 1874 1885
91. A.D. Mooradian Age-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) Mech. Ageing Dev. 124 2003 143 146 (Pubitemid 36293922)
92. R. Dei Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease Acta Neuropathol. 104 2002 113 122 (Pubitemid 36075368)
93. M. Letiembre Innate immune receptor expression in normal brain aging Neuroscience 146 2007 248 254 (Pubitemid 46661885)
94. N.C. Berchtold Gene expression changes in the course of normal brain aging are sexually dimorphic Proc. Natl. Acad. Sci. U.S.A. 105 2008 15605 15610
95. D.J. Maron Current perspectives on statins Circulation 101 2000 207 213 (Pubitemid 30044262)
96. A.D. Mooradian Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats Diabetes 54 2005 2977 2982 (Pubitemid 41401095)
97. R.L. Sacco, and J.K. Liao Drug insight: statins and stroke Nat. Clin. Pract. Cardiovasc. Med. 2 2005 576 584 (Pubitemid 41655661)
98. M. Takemoto, and J.K. Liao Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors Arterioscler. Thromb. Vasc. Biol. 21 2001 1712 1719 (Pubitemid 34219772)
99. G. Liot 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo J. Cereb. Blood Flow Metab. 24 2004 1153 1159 (Pubitemid 39332154)
100. A. Zacco 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity J. Neurosci. 23 2003 11104 11111 (Pubitemid 37548945)
101. S. Wang Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes Stroke 37 2006 1910 1912 (Pubitemid 44297750)
102. E. Kilic Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase Stroke 36 2005 332 336 (Pubitemid 40170818)
103. P. Amarenco High-dose atorvastatin after stroke or transient ischemic attack N. Engl. J. Med. 355 2006 549 559 (Pubitemid 44202151)
104. K.H. Palnum Use of secondary medical prophylaxis and clinical outcome among patients with ischemic stroke: a nationwide follow-up study Stroke 43 2012 802 807
105. Trowbridge RL ACP Journal Club. Review: Insufficient evidence exists to determine the benefits and risks of statins for acute stroke or TIA Ann. Intern. Med. 155 2011 JC6-JC6
106. J. Alvarez-Sabin Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator Stroke 38 2007 1076 1078 (Pubitemid 46568478)
107. N. Meier Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke Stroke 40 2009 1729 1737
108. I. Miedema Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke Cerebrovasc. Dis. 29 2010 263 267
109. N. Makihara Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry Cerebrovasc. Dis. 33 2012 240 247
110. M. Cappellari Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study J. Neurol. Sci. 308 2011 128 134
111. O. Coux Structure and functions of the 20S and 26S proteasomes Annu. Rev. Biochem. 65 1996 801 847 (Pubitemid 26255262)
112. C. Wojcik, and M. Di Napoli Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy Stroke 35 2004 1506 1518 (Pubitemid 38697484)
113. J. Adams Proteasome inhibitors: a novel class of potent and effective antitumor agents Cancer Res. 59 1999 2615 2622 (Pubitemid 29269108)
114. R.C. Kane Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy Oncologist 8 2003 508 513 (Pubitemid 37467365)
115. B. Campbell Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart J. Mol. Cell. Cardiol. 31 1999 467 476 (Pubitemid 29089894)
116. E.M. Conner Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis J. Pharmacol. Exp. Ther. 282 1997 1615 1622 (Pubitemid 27408348)
117. C.L. Vanderlugt Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519 J. Autoimmun. 14 2000 205 211
118. K. Stangl, and V. Stangl The ubiquitin-proteasome pathway and endothelial (dys)function Cardiovasc. Res. 85 2010 281 290
119. P.L. Huang Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 1995 239 242
120. N. Yamamoto Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease J. Biol. Chem. 282 2007 4364 4372 (Pubitemid 47101000)
121. J. Chen, and R.F. Regan Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury Curr. Neurovasc. Res. 2 2005 189 196 (Pubitemid 40980178)
122. M. Lorenz Proteasome inhibition prevents experimentally-induced endothelial dysfunction Life Sci. 84 2009 929 934
123. H. Dreger Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2 Cardiovasc Res. 85 2010 395 403
124. L. Zhang Postischemic (6-hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia Stroke 32 2001 2926 2931 (Pubitemid 33134491)
125. L. Zhang Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator Thromb. Haemost. 95 2006 166 173
126. M.C. Minnema Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI J. Clin. Invest. 101 1998 10 14
127. T. Huynh Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project Am. Heart J. 148 2004 86 91 (Pubitemid 38900484)
128. R. Abbate Age-related changes in the hemostatic system Int. J. Clin. Lab. Res. 23 1993 1 3
129. M.A. Yenari Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro Stroke 37 2006 1087 1093
130. L.S. Machado Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke BMC Neurosci. 7 2006 56
131. M. Koistinaho Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice J. Cereb. Blood Flow Metab. 25 2005 460 467
132. Y. Murata Extension of the thrombolytic time window with minocycline in experimental stroke Stroke 39 2008 3372 3377
133. Y. Lampl Minocycline treatment in acute stroke: an open-label, evaluator-blinded study Neurology 69 2007 1404 1410 (Pubitemid 47511461)
134. S.C. Fagan Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study Stroke 41 2010 2283 2287
135. J.A. Switzer Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke Stroke 42 2012 2633 2635
136. P.H. Chan Oxygen radicals in focal cerebral ischemia Brain Pathol. 4 1994 59 65 (Pubitemid 24077892)
137. J.H. Heo Free radicals as triggers of brain edema formation after stroke Free Radic. Biol. Med. 39 2005 51 70
138. G.W. Kim The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood-brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in mice Neuroscience 105 2001 1007 1018 (Pubitemid 32786813)
139. R. Schmid-Elsaesser Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia Stroke 28 1997 2018 2024 (Pubitemid 27459013)
140. P.A. Lapchak Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator Stroke 32 2001 147 153 (Pubitemid 32063839)
141. K. Yagi Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator Stroke 40 2009 626 631
142. T. Yamashita Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain J. Cereb. Blood Flow Metab. 29 2009 715 725
143. S. Amaro, and A. Chamorro Translational stroke research of the combination of thrombolysis and antioxidant therapy Stroke 42 2011 1495 1499
144. K. Kimura Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients - a preliminary study J. Neurol. Sci. 313 2012 132 136
145. Y. Li Erythropoietin prevents blood-brain barrier damage induced by focal cerebral ischemia in mice Neurochem. Res. 32 2007 2132 2141 (Pubitemid 350059857)
146. Y. Wang Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia Br. J. Pharmacol. 151 2007 1377 1384 (Pubitemid 47255890)
147. A.L. Siren Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress Proc. Natl. Acad. Sci. U.S.A. 98 2001 4044 4049
148. N. Byts, and A.L. Siren Erythropoietin: a multimodal neuroprotective agent Exp. Transl. Stroke Med. 1 2009 4
149. H. Ehrenreich Recombinant human erythropoietin in the treatment of acute ischemic stroke Stroke 40 2009 e647 e656
150. A. Zechariah Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice Stroke 41 2010 1008 1012